Abstract
Activation of NF-kappaB following genotoxic stress allows time for DNA-damage repair and ensures cell survival accounting for acquired chemoresistance, an impediment to effective cancer therapy. Despite this clinical relevance, little is known about pathways that enable genotoxic-stress-induced NF-kappaB induction. Previously, we reported a role for the p53-inducible death-domain-containing protein, PIDD, in caspase-2 activation and apoptosis in response to DNA damage. We now demonstrate that PIDD plays a critical role in DNA-damage-induced NF-kappaB activation. Upon genotoxic stress, a complex between PIDD, the kinase RIP1, and a component of the NF-kappaB-activating kinase complex, NEMO, is formed. PIDD expression enhances genotoxic-stress-induced NF-kappaB activation through augmented sumoylation and ubiquitination of NEMO. Depletion of PIDD and RIP1, but not caspase-2, abrogates DNA-damage-induced NEMO modification and NF-kappaB activation. We propose that PIDD acts as a molecular switch, controlling the balance between life and death upon DNA damage.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adaptor Proteins, Signal Transducing / genetics
-
Binding, Competitive
-
CRADD Signaling Adaptor Protein
-
Carrier Proteins / genetics
-
Carrier Proteins / metabolism
-
Carrier Proteins / physiology*
-
Caspase 2
-
Caspases / genetics
-
Caspases / metabolism
-
Cell Line, Tumor
-
Cell Nucleus / drug effects
-
Cell Nucleus / metabolism
-
DNA / genetics
-
DNA / metabolism
-
DNA Damage / physiology*
-
Death Domain Receptor Signaling Adaptor Proteins
-
Doxorubicin / pharmacology
-
Etoposide / pharmacology
-
Fatty Acids, Unsaturated / pharmacology
-
HeLa Cells
-
Humans
-
Hypotonic Solutions / pharmacology
-
I-kappa B Kinase / metabolism
-
I-kappa B Proteins / metabolism
-
Jurkat Cells
-
Models, Biological
-
NF-kappa B / metabolism*
-
Nuclear Pore Complex Proteins / genetics
-
Nuclear Pore Complex Proteins / metabolism
-
Phosphorylation / drug effects
-
Protein Binding
-
Protein Transport / drug effects
-
RNA, Small Interfering / genetics
-
RNA-Binding Proteins / genetics
-
RNA-Binding Proteins / metabolism
-
Small Ubiquitin-Related Modifier Proteins / metabolism
-
Transfection
-
Tumor Necrosis Factor-alpha / pharmacology
-
Ubiquitin / metabolism
-
X-Linked Inhibitor of Apoptosis Protein / metabolism
-
bcl-X Protein / metabolism
Substances
-
AGFG1 protein, human
-
Adaptor Proteins, Signal Transducing
-
BCL2L1 protein, human
-
CRADD Signaling Adaptor Protein
-
CRADD protein, human
-
Carrier Proteins
-
Death Domain Receptor Signaling Adaptor Proteins
-
Fatty Acids, Unsaturated
-
Hypotonic Solutions
-
I-kappa B Proteins
-
IKBKG protein, human
-
NF-kappa B
-
Nuclear Pore Complex Proteins
-
PIDD1 protein, human
-
RNA, Small Interfering
-
RNA-Binding Proteins
-
Small Ubiquitin-Related Modifier Proteins
-
Tumor Necrosis Factor-alpha
-
Ubiquitin
-
X-Linked Inhibitor of Apoptosis Protein
-
XIAP protein, human
-
bcl-X Protein
-
Etoposide
-
Doxorubicin
-
DNA
-
I-kappa B Kinase
-
Caspase 2
-
Caspases
-
leptomycin B